Adenoviral Vector Reuse in Respiratory Mucosal Vaccination: Immune Barriers, Transduction, and Memory Recall

Respiratory mucosal vaccination with adenoviral vectors can induce secretory IgA and tissue-resident memory B and T cells, yet immune responses to the vector may compromise subsequent administrations. Antibodies recognizing adenoviral capsid proteins can interfere with receptor engagement and cellular entry, whereas cytosolic TRIM21 promotes the proteasomal degradation of antibody-coated virions. Cross-reactive adenovirus-specific T cells can accelerate the clearance of transduced cells, while innate DNA sensing through cGAS and STING influences antigen presentation and antiviral restriction. The consequences of these mechanisms vary across respiratory compartments according to epithelial receptor accessibility, vector deposition, and the distribution of local immune effectors. This Review examines how these factors determine the mucosal transduction reserve, defined as the residual capacity for productive antigen delivery and expression after previous vector exposure. Effective homologous boosting depends on whether the remaining antigen expression is sufficient to reactivate local immunological memory, a requirement conceptualized as the antigen recall threshold. The relationship between residual transduction and memory reactivation provides a mechanistic basis for the proposed mucosal reusability window. Preclinical evidence suggests that detectable immunity against adenovirus does not necessarily prevent subsequent boosting. Capsid engineering, targeted respiratory deposition and optimization of dosing intervals may preserve vector function, but their effects on repeated mucosal administration require longitudinal evaluation of local vector immunity, early transgene expression and tissue-resident immune recall.

Authors

Institutions

Publication Details

Journal
Vaccines
Published
2026-11-12
DOI
https://doi.org/10.3390/vaccines14110973
Primary Topic
Virus-based gene therapy research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Adenoviral Vector Reuse in Respiratory Mucosal Vaccination: Immune Barriers, Transduction, and Memory Recall

Zhi Wu, Shinuo Cao, Mo Zhou, Shanyuan Zhu
Vaccines
Virus-based gene therapy research
article

Adenoviral Vector Reuse in Respiratory Mucosal Vaccination: Immune Barriers, Transduction, and Memory Recall

Zhi Wu, Shinuo Cao, Mo Zhou, Shanyuan Zhu
article en

Abstract

Respiratory mucosal vaccination with adenoviral vectors can induce secretory IgA and tissue-resident memory B and T cells, yet immune responses to the vector may compromise subsequent administrations. Antibodies recognizing adenoviral capsid proteins can interfere with receptor engagement and cellular entry, whereas cytosolic TRIM21 promotes the proteasomal degradation of antibody-coated virions. Cross-reactive adenovirus-specific T cells can accelerate the clearance of transduced cells, while innate DNA sensing through cGAS and STING influences antigen presentation and antiviral restriction. The consequences of these mechanisms vary across respiratory compartments according to epithelial receptor accessibility, vector deposition, and the distribution of local immune effectors. This Review examines how these factors determine the mucosal transduction reserve, defined as the residual capacity for productive antigen delivery and expression after previous vector exposure. Effective homologous boosting depends on whether the remaining antigen expression is sufficient to reactivate local immunological memory, a requirement conceptualized as the antigen recall threshold. The relationship between residual transduction and memory reactivation provides a mechanistic basis for the proposed mucosal reusability window. Preclinical evidence suggests that detectable immunity against adenovirus does not necessarily prevent subsequent boosting. Capsid engineering, targeted respiratory deposition and optimization of dosing intervals may preserve vector function, but their effects on repeated mucosal administration require longitudinal evaluation of local vector immunity, early transgene expression and tissue-resident immune recall.

VaccinesVol. 14(11)
Jiangsu Agri-animal Husbandry Vocational College (CN)
Taizhou Municipal Science and Technology Bureau, Jiangsu Agri-animal Husbandry Vocational College
Good health and well-being
Virus-based gene therapy research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon